
Comparison of first-year results of tenofovir and entecavir treatments of nucleos(t)ide-naive chronic hepatitis B patients with hepatosteatosis
Author(s) -
Zeynal Doğan,
Levent Filik,
Bilal Ergül,
Murat Sarıkaya
Publication year - 2015
Publication title -
the saudi journal of gastroenterology/saudi journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.608
H-Index - 32
eISSN - 1998-4049
pISSN - 1319-3767
DOI - 10.4103/1319-3767.164186
Subject(s) - entecavir , medicine , gastroenterology , chronic hepatitis , tenofovir , hepatitis b , virology , lamivudine , virus , human immunodeficiency virus (hiv)
Hepatic steatosis may influence the response to antivirals in chronic hepatitis B patients. This study aimed to compare the efficacy of entecavir and tenofovir in nucleos(t) ide-naive chronic hepatitis B patients with hepatosteatosis during 48 weeks of therapy.